These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
386 related articles for article (PubMed ID: 23593217)
21. Targeted deletion of BCL11A gene by CRISPR-Cas9 system for fetal hemoglobin reactivation: A promising approach for gene therapy of beta thalassemia disease. Khosravi MA; Abbasalipour M; Concordet JP; Berg JV; Zeinali S; Arashkia A; Azadmanesh K; Buch T; Karimipoor M Eur J Pharmacol; 2019 Jul; 854():398-405. PubMed ID: 31039344 [TBL] [Abstract][Full Text] [Related]
22. Metformin induces FOXO3-dependent fetal hemoglobin production in human primary erythroid cells. Zhang Y; Paikari A; Sumazin P; Ginter Summarell CC; Crosby JR; Boerwinkle E; Weiss MJ; Sheehan VA Blood; 2018 Jul; 132(3):321-333. PubMed ID: 29884740 [TBL] [Abstract][Full Text] [Related]
23. MYB controls erythroid versus megakaryocyte lineage fate decision through the miR-486-3p-mediated downregulation of MAF. Bianchi E; Bulgarelli J; Ruberti S; Rontauroli S; Sacchi G; Norfo R; Pennucci V; Zini R; Salati S; Prudente Z; Ferrari S; Manfredini R Cell Death Differ; 2015 Dec; 22(12):1906-21. PubMed ID: 25857263 [TBL] [Abstract][Full Text] [Related]
24. BCL11A-targeted γ-globin gene induction by triterpenoid glycosides of Fagonia indica: A preclinical scientific validation of indigenous herb for the treatment of β-hemoglobinopathies. Iftikhar F; Khan MBN; Tehreem S; Kanwal N; Musharraf SG Bioorg Chem; 2023 Nov; 140():106768. PubMed ID: 37586133 [TBL] [Abstract][Full Text] [Related]
25. Development of a double shmiR lentivirus effectively targeting both BCL11A and ZNF410 for enhanced induction of fetal hemoglobin to treat β-hemoglobinopathies. Liu B; Brendel C; Vinjamur DS; Zhou Y; Harris C; McGuinness M; Manis JP; Bauer DE; Xu H; Williams DA Mol Ther; 2022 Aug; 30(8):2693-2708. PubMed ID: 35526095 [TBL] [Abstract][Full Text] [Related]
26. Correction of sickle cell disease in adult mice by interference with fetal hemoglobin silencing. Xu J; Peng C; Sankaran VG; Shao Z; Esrick EB; Chong BG; Ippolito GC; Fujiwara Y; Ebert BL; Tucker PW; Orkin SH Science; 2011 Nov; 334(6058):993-6. PubMed ID: 21998251 [TBL] [Abstract][Full Text] [Related]
27. Potent and uniform fetal hemoglobin induction via base editing. Mayuranathan T; Newby GA; Feng R; Yao Y; Mayberry KD; Lazzarotto CR; Li Y; Levine RM; Nimmagadda N; Dempsey E; Kang G; Porter SN; Doerfler PA; Zhang J; Jang Y; Chen J; Bell HW; Crossley M; Bhoopalan SV; Sharma A; Tisdale JF; Pruett-Miller SM; Cheng Y; Tsai SQ; Liu DR; Weiss MJ; Yen JS Nat Genet; 2023 Jul; 55(7):1210-1220. PubMed ID: 37400614 [TBL] [Abstract][Full Text] [Related]
28. Effects of Mithramycin on BCL11A Gene Expression and on the Interaction of the BCL11A Transcriptional Complex to γ-Globin Gene Promoter Sequences. Finotti A; Gasparello J; Zuccato C; Cosenza LC; Fabbri E; Bianchi N; Gambari R Genes (Basel); 2023 Oct; 14(10):. PubMed ID: 37895276 [TBL] [Abstract][Full Text] [Related]
29. Activating transcription factor 4 in erythroid development and Li J; Lv A; Chen M; Xu L; Huang H Ann Hematol; 2024 Aug; 103(8):2659-2670. PubMed ID: 37906269 [TBL] [Abstract][Full Text] [Related]
31. The Novel Role of the B-Cell Lymphoma/Leukemia 11A (BCL11A) Gene in β-Thalassaemia Treatment. Mahmoud Ahmed NH; Lai MI Cardiovasc Hematol Disord Drug Targets; 2023; 22(4):226-236. PubMed ID: 36734897 [TBL] [Abstract][Full Text] [Related]
32. Hydroxyurea down-regulates BCL11A, KLF-1 and MYB through miRNA-mediated actions to induce γ-globin expression: implications for new therapeutic approaches of sickle cell disease. Pule GD; Mowla S; Novitzky N; Wonkam A Clin Transl Med; 2016 Mar; 5(1):15. PubMed ID: 27056246 [TBL] [Abstract][Full Text] [Related]
34. Transcriptional silencing of fetal hemoglobin by BCL11A. Sankaran VG; Xu J; Orkin SH Ann N Y Acad Sci; 2010 Aug; 1202():64-8. PubMed ID: 20712774 [TBL] [Abstract][Full Text] [Related]
35. miR-365-3p mediates BCL11A and SOX6 erythroid-specific coregulation: A new player in HbF activation. Simbula M; Manchinu MF; Mingoia M; Pala M; Asunis I; Caria CA; Perseu L; Shah M; Crossley M; Moi P; Ristaldi MS Mol Ther Nucleic Acids; 2023 Dec; 34():102025. PubMed ID: 37744176 [TBL] [Abstract][Full Text] [Related]
36. Enhanced erythroid cell differentiation in hypoxic condition is in part contributed by miR-210. Sarakul O; Vattanaviboon P; Tanaka Y; Fucharoen S; Abe Y; Svasti S; Umemura T Blood Cells Mol Dis; 2013 Aug; 51(2):98-103. PubMed ID: 23623309 [TBL] [Abstract][Full Text] [Related]
37. IOX1 Fails to Reduce α-Globin and Mediates γ-Globin Silencing in Adult β Khamphikham P; Wongborisuth C; Pornprasert S; Tantiworawit A; Tangprasittipap A; Songdej D; Hongeng S Exp Hematol; 2022; 112-113():9-14.e7. PubMed ID: 35839944 [TBL] [Abstract][Full Text] [Related]
38. Simvastatin and t-butylhydroquinone suppress KLF1 and BCL11A gene expression and additively increase fetal hemoglobin in primary human erythroid cells. Macari ER; Schaeffer EK; West RJ; Lowrey CH Blood; 2013 Jan; 121(5):830-9. PubMed ID: 23223429 [TBL] [Abstract][Full Text] [Related]
39. Acyclovir induces fetal hemoglobin via downregulation of γ-globin repressors, BCL11A and SOX6 trans-acting factors. Ali H; Khan F; Ghulam Musharraf S Biochem Pharmacol; 2021 Aug; 190():114612. PubMed ID: 34010599 [TBL] [Abstract][Full Text] [Related]
40. Distinct miRNA Signatures and Networks Discern Fetal from Adult Erythroid Differentiation and Primary from Immortalized Erythroid Cells. Papasavva PL; Papaioannou NY; Patsali P; Kurita R; Nakamura Y; Sitarou M; Christou S; Kleanthous M; Lederer CW Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33807258 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]